Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New oral antithrombotics: a need for laboratory monitoring. Against.

× No keyword cloud information.

12 in total

1. [New anticoagulant drugs for atrial fibrillation. Feasibility and necessity of monitoring].

Authors: K Madlener; C Hamm
Journal: Herz Date: 2012-06 Impact factor: 1.443

Review 2. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal: Chest Date: 2012-02 Impact factor: 9.410

3. Assessment of trough rivaroxaban concentrations on markers of coagulation activation in nonvalvular atrial fibrillation population.

Authors: Fumihiko Kitagawa; Junnichi Ishii; Shinya Hiramitsu; Hiroshi Takahashi; Ryuunosuke Okuyama; Hideki Kawai; Takashi Muramatsu; Masahide Harada; Sadako Motoyama; Hiroyuki Naruse; Shigeru Matsui; Masayoshi Sarai; Mutsuharu Hayashi; Eiichi Watanabe; Hideo Izawa; Yukio Ozaki
Journal: Heart Vessels Date: 2016-10-28 Impact factor: 2.037

Review 4. New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Authors: Francesco Scaglione
Journal: Clin Pharmacokinet Date: 2013-02 Impact factor: 6.447

Review 5. New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function.

Authors: Birgitte Klindt Poulsen; Erik Lerkevang Grove; Steen Elkjaer Husted
Journal: Drugs Date: 2012-09-10 Impact factor: 9.546

6. Glomerular filtration rate estimated by Cockcroft-Gault formula better predicts anti-Xa levels than modification of the diet in renal disease equation in older patients with prophylactic enoxaparin.

Authors: B Dufour; M Toussaint-Hacquard; A Kearney-Schwartz; M D P Manckoundia; M C Laurain; L Joly; J Deibener; D Wahl; T Lecompte; A Benetos; C Perret-Guillaume
Journal: J Nutr Health Aging Date: 2012-07 Impact factor: 4.075

7. Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation.

Authors: Saartje Bloemen; H Coenraad Hemker; Raed Al Dieri
Journal: Haematologica Date: 2012-10-25 Impact factor: 9.941

8. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability.

Authors: Job Harenberg; Roland Krämer; Christina Giese; Svetlana Marx; Christel Weiss; Martin Wehling
Journal: J Thromb Thrombolysis Date: 2011-10 Impact factor: 2.300

Review 9. Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations.

Authors: Jonathan Douxfils; Helen Mani; Valentine Minet; Bérangère Devalet; Bernard Chatelain; Jean-Michel Dogné; François Mullier
Journal: Biomed Res Int Date: 2015-05-19 Impact factor: 3.411

10. Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.

Authors: Ekta Yogeshkumar Pandya; Elizabeth Anderson; Clara Chow; Yishen Wang; Beata Bajorek
Journal: Ther Adv Drug Saf Date: 2017-12-13